Rituximab - 10mg/ml solution

Rituximab - 10mg/ml solution

Catalog Number:
L002235261BIO
Mfr. No.:
BR167936
Price:
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Rituximab is a glycosylated monoclonal antibody that binds to the CD20 cell surface protein which is widely expressed on B-cells. Through the binding of rituximab’s Fc portion, the antibody-dependent cellular cytotoxicity pathway (ADCC) and the complement-dependent cytotoxicity (CDC) pathway are initiated, both leading to B-cell lysis (Chisari, 2021). In addition, direct apoptosis can be the result of the inhibition of various B-cell signalling pathways. Rituximab is used in targeted therapy for chronic lymphocytic leukaemia (CLL), non-Hodgkin lymphoma (NHL) and some non-cancer pathologies, such as, multiple sclerosis (Johnson, 2001).

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          Protein Interactions
          CAS Number
          174722-31-7
          Molecular Formula
          C6416H9874N1688O1987S44
          Molecular Weight
          143.86 kg/mol
          Note
          There is no hazardous surcharge associated with this product.
          There is no special packaging charge associated with this product.

          * For research use only. Not for human or veterinary use

      • Reference
        • Chisari et al (2021) Rituximab for the treatment of multiple sclerosis: a review, Journal Neurology.
          Johnson et al (2001) Rituximab: mechanisms and applications, British Journal of Cancer, 85, 1619-1623.

    Documents

    Specification

    Note: If you don't receive our verification email, do the following:

    • Confirm that you entered your email address correctly.
    • Check if the email is in your spam or junk folder.
    • Or you may contact us at .
    Copyright © Amerigo Scientific. All rights reserved.